S.E.E.D. Planning Group LLC Acquires 9,177 Shares of Corteva, Inc. $CTVA

S.E.E.D. Planning Group LLC raised its stake in shares of Corteva, Inc. (NYSE:CTVA) by 5.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 173,570 shares of the company’s stock after purchasing an additional 9,177 shares during the quarter. Corteva accounts for 3.4% of S.E.E.D. Planning Group LLC’s portfolio, making the stock its 13th largest holding. S.E.E.D. Planning Group LLC’s holdings in Corteva were worth $11,739,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Gladwyn Financial Advisors Inc. bought a new stake in Corteva in the second quarter valued at $25,000. Total Investment Management Inc. acquired a new stake in shares of Corteva in the 2nd quarter valued at $27,000. Curat Global LLC grew its holdings in shares of Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares during the last quarter. Maryland Capital Advisors Inc. acquired a new stake in shares of Corteva during the 2nd quarter worth about $29,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Corteva during the 2nd quarter valued at about $29,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 0.9%

NYSE CTVA opened at $66.39 on Monday. The stock has a market capitalization of $44.86 billion, a P/E ratio of 28.37, a price-to-earnings-growth ratio of 1.50 and a beta of 0.74. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $77.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.07 and a current ratio of 1.58. The stock has a fifty day moving average of $64.54 and a 200-day moving average of $69.30.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.49) by $0.26. The business had revenue of $2.62 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The firm’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the business earned ($0.49) earnings per share. On average, equities research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, December 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, December 1st. This represents a $0.72 annualized dividend and a dividend yield of 1.1%. Corteva’s payout ratio is currently 30.77%.

Wall Street Analyst Weigh In

CTVA has been the topic of several research analyst reports. Morgan Stanley set a $84.00 price objective on shares of Corteva in a research note on Monday, September 15th. BNP Paribas Exane raised their price target on Corteva from $70.00 to $72.00 and gave the company a “neutral” rating in a report on Monday, November 17th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 30th. KeyCorp restated a “sector weight” rating on shares of Corteva in a report on Friday, October 3rd. Finally, Mizuho cut their price target on Corteva from $85.00 to $78.00 and set an “outperform” rating for the company in a report on Wednesday, October 8th. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $78.21.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.